An FDA report on bioresearch monitoring FY 2023 metrics documents nearly 1,100 inspections through FDAs five Centers.
The United States Court of Appeals for the DC Circuit grants a Novartis motion to stay FDAs approval of MSN Laboratories generic version of Novartiss ...
FDA approves an Abbott labeling change on its HeartMate 3 heart pump to eliminate aspirin as part of routine patient management.
A New York Times investigative article examines potential conflicts of interest with retiring CDRH director Jeff Shuren and his lawyer wife who repres...
Federal Register notice: FDA determines that Horizon Therapeutics Pennsaid (diclofenac sodium) topical solution 2% was not withdrawn due to safety or ...
Federal Register notice: FDA makes available a final guidance entitled Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA....
FDA approves a Johnson & Johnson BLA for Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) for the first-line treatment of certain adult patient...
FDA clears a SI-Bone 510(k) for the iFuse Torq TNT Implant System for pelvic fragility fracture fixation and sacroiliac joint fusion.